- Condition: Late Life Depression
Intervention: Drug: Mirtazapine
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2012 - Condition: Hyperlipidemia
Intervention: Drug: Sitagliptin
Sponsors: University Health Network, Toronto; University Health Network, Toronto; Merck Frosst Canada Ltd.
Not yet recruiting - verified April 2012 - Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel, 0.015%; Drug: Vehicle gel
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified May 2012 - Conditions: Healthy Infants; Immunization; Pain Management
Intervention: Behavioral: Tactile stimulation
Sponsors: University of Toronto; University of Toronto
Not yet recruiting - verified May 2012 - Condition: Multiple Sclerosis
Interventions: Drug: PR Fampridine; Other: Placebo
Sponsors: Biogen Idec; Biogen Idec
Not yet recruiting - verified May 2012 - Condition: Voiding Dysfunction After Pelvic Organ Prolapse Surgery
Intervention: Procedure: CISC instruction pre-operatively
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto
Not yet recruiting - verified May 2012 - Condition: Spinal Cord Injury
Interventions: Drug: Riluzole; Drug: Placebo; Other: No intervention
Sponsors: SpineNet; SpineNet
Not yet recruiting - verified May 2012 - Conditions: To Determine the Effects of an ad Libitum Intake of 1%; Milk, Fruit Juice, Regular Soda, Diet Soda and Water, as Part of a Pizza Meal, on Meal Food Intake, Appetite and Postprandial Blood Glucose in Healthy Men and; Women.
Intervention: Other: Nutritional Intervention
Sponsors: University of Toronto; University of Toronto
Active, not recruiting - verified June 2011 - Conditions: Depressive Disorder; Schizophrenia; Obsessive-Compulsive Disorder
Intervention: Device: Magnetic Seizure Therapy (MagPro MST)
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health; University Health Network, Toronto
Recruiting - verified May 2012 - Conditions: HER2 + Breast Cancer; HER2 + Gastric Cancer; Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: LJM716
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Psychomotor Impairment
Interventions: Drug: delta-9-tetrahydrocannabinol; Drug: Placebo
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health; Canadian Institutes of Health Research (CIHR); Health Canada
Not yet recruiting - verified May 2012 - Conditions: End Stage Renal Disease; Venous Stenosis
Intervention: Drug: Sirolimus
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Pfizer
Recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Severe Sepsis
Interventions: Drug: Vitamin C; Drug: placebo
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2012 - Condition: Early-Stage Squamous Cell Carcinoma of the Oropharynx
Interventions: Radiation: Radiotherapy; Procedure: Transoral Robotic Surgery + Neck Dissection
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2012 - Condition: Type 1 Diabetes
Intervention: Device: Pump suspension
Sponsors: In Home Closed Loop Study Group; In Home Closed Loop Study Group; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified May 2012 - Conditions: Dyslipidemia; Diabetes; Prediabetes; Dysglycemia; Overweight; Obesity; Hypertension; Metabolic Syndrome; Cardiovascular Disease
Intervention: Other: Dietary pulses
Sponsors: University of Toronto; University of Toronto; Canadian Institutes of Health Research (CIHR); Canada Research Chair Endowment of the Federal Government of Canada; Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship Award; Pulse Canada
Active, not recruiting - verified April 2012 - Condition: Neuroblastoma
Intervention:
Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy Consortium
Recruiting - verified April 2012 - Condition: Traumatic Intracranial Haemorrhage
Interventions: Drug: Enoxaparin; Other: Placebo
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified April 2012 - Conditions: Gambling; Pathological Gambling
Interventions: Behavioral: Treatment as Usual; Behavioral: Cognitive Motivational Behavior Therapy; Behavioral: 12-week wait list
Sponsors: National Institute on Drug Abuse (NIDA); Ontario Problem Gambling Research Centre; Wayne State University; Windsor Regional Hospital
Recruiting - verified May 2012 - Condition: Psoriasis
Interventions: Drug: ustekinumab; Drug: placebo
Sponsors: Centocor Research & Development, Inc.; Centocor Research & Development, Inc.
Completed - verified April 2012 - Condition: Distal Radius Fracture
Interventions: Procedure: Open Reduction and Internal Fixation; Procedure: External Fixation; Procedure: Percutaneous Pinning; Procedure: Closed Reduction and casting
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Reflex Sympathetic Dystrophy
Intervention:
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Recruiting - verified April 2012 - Conditions: Cervical Deformity; Kyphosis; Scoliosis
Intervention:
Sponsors: International Spine Study Group Foundation; International Spine Study Group Foundation; DePuy Spine
Enrolling by invitation - verified April 2012 - Condition: Rheumatoid Arthritis (RA)
Interventions: Other: DAS28-IOMS; Other: 0SJ-IOMS; Other: Routine Care (RC)
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Abbott
Completed - verified April 2012 - Conditions: Lung Cancer; Breathlessness
Intervention: Behavioral: Self-management Intervention
Sponsors: University Health Network, Toronto; University Health Network, Toronto; National Lung Cancer Partnership; Oncology Nursing Society Foundation; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Prostate Cancer
Intervention: Radiation: focal salvage HDR prostate brachytherapy
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Association of Radiation Oncology
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Condition: Gestational Diabetes Mellitus
Interventions: Other: Low GI diet; Other: Standard Care
Sponsors: University of Toronto; University of Toronto; Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR); Canadian Foundation for Dietetic Research (CFDR)
Recruiting - verified April 2012 - Condition: Acute Respiratory Distress Syndrome
Intervention:
Sponsors: Canadian Critical Care Trials Group; Canadian Critical Care Trials Group; Canadian Intensive Care Foundation
Recruiting - verified April 2012 - Condition: Patients Discharged From General Internal Medicine.
Intervention:
Sponsors: Mount Sinai Hospital, Canada; Mount Sinai Hospital, Canada
Not yet recruiting - verified April 2012
 |
Paid Clinical Trials in Ontario Canada |
Clinical Trial Locations 